Tokio Marine Asset Management Co. Ltd. acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,134 shares of the company’s stock, valued at approximately $301,000.
Other hedge funds also recently made changes to their positions in the company. Huntington National Bank lifted its holdings in shares of Henry Schein by 16.8% in the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after purchasing an additional 218 shares during the last quarter. Speece Thorson Capital Group Inc. lifted its stake in Henry Schein by 20.0% in the third quarter. Speece Thorson Capital Group Inc. now owns 235,967 shares of the company’s stock valued at $17,202,000 after buying an additional 39,352 shares during the last quarter. Entropy Technologies LP boosted its holdings in shares of Henry Schein by 29.3% in the third quarter. Entropy Technologies LP now owns 22,096 shares of the company’s stock valued at $1,611,000 after acquiring an additional 5,005 shares during the period. River Global Investors LLP grew its position in shares of Henry Schein by 12.3% during the third quarter. River Global Investors LLP now owns 140,386 shares of the company’s stock worth $10,237,000 after acquiring an additional 15,336 shares during the last quarter. Finally, Covestor Ltd increased its holdings in shares of Henry Schein by 31.2% in the 3rd quarter. Covestor Ltd now owns 1,987 shares of the company’s stock valued at $144,000 after acquiring an additional 473 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.
Henry Schein Price Performance
Henry Schein stock opened at $68.76 on Friday. The company has a market cap of $8.57 billion, a P/E ratio of 28.30, a price-to-earnings-growth ratio of 1.94 and a beta of 0.87. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The business has a fifty day moving average of $70.30 and a two-hundred day moving average of $69.57. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.
Analysts Set New Price Targets
HSIC has been the subject of a number of recent research reports. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research reissued an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $78.89.
Get Our Latest Analysis on Henry Schein
Insider Transactions at Henry Schein
In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.14% of the company’s stock.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- How to Use the MarketBeat Stock Screener
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Best Stocks Under $10.00
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Basic Materials Stocks Investing
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.